Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03414411 · ClinicalTrials.gov registry record
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort: The 4F Study
A clinical trial, sponsored by Boston University.
- Completed
- Registry status
- 251
- Enrollment target
NCT03414411 is a clinical trial that has completed, run by Boston University. The registered enrollment target is 251 participants.
The verdict
NCT03414411 has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- 251 participants
- Enrollment target
Study Summary
The purpose of this study is to follow a cohort of HIV-infected adults who have alcohol and/or drug use to: 1) test the associations between alcohol (and illicit drugs and polypharmacy (multiple prescribed medications)) and falls (fractures secondarily), and whether frailty mediates these associations; and 2) test the associations between alcohol (and illicit drugs and polypharmacy) and utilization (emergency department use and hospitalization for falls and fractures), and whether frailty mediates them. To achieve the stated aims the investigators will expand (to 400) and continue to follow an existing prospective cohort (The Boston ARCH Cohort) of adults with HIV infection and a high prevalence of exposure to alcohol, other drugs, and polypharmacy. The Boston ARCH Cohort is a longitudinal cohort (1-3.5 years of follow-up) of 250 HIV-infected men and women with current substance dependence or ever injection drug use that have a spectrum of alcohol use.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2018-02-20 |
| Est. Completion | 2023-04-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03414411
The ClinicalTrials.gov registry entry for NCT03414411 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03414411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03414411 about?
NCT03414411 is a clinical study titled "Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort: The 4F Study". The purpose of this study is to follow a cohort of HIV-infected adults who have alcohol and/or drug use to: 1) test the associations between alcohol (and illicit drugs and polypharmacy (multiple prescribed medications)) and falls (fractures secondarily), and whether frailty mediates these associatio...
What is the current status of trial NCT03414411?
This trial is currently completed. The enrollment target is 251 participants. The study started on 2018-02-20. Estimated completion is 2023-04-27.
Who is sponsoring clinical trial NCT03414411?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.